These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36247270)

  • 1. The prognostic and immune infiltration role of ITGB superfamily members in non-small cell lung cancer.
    Wu J; Wang W; Li Z; Ye X
    Am J Transl Res; 2022; 14(9):6445-6466. PubMed ID: 36247270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINC00628 is differentially expressed between lung adenocarcinoma and squamous cell carcinoma and is associated with the prognosis of NSCLC.
    Liu T; Xu S; Liu X
    Oncol Lett; 2022 Feb; 23(2):55. PubMed ID: 34992687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index.
    Wu R; Ma R; Duan X; Zhang J; Li K; Yu L; Zhang M; Liu P; Wang C
    Front Immunol; 2023; 14():1236444. PubMed ID: 37841237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Li Y; Zheng P; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. System analysis of
    Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
    Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the biological functions and chemo-therapeutic responses of ITGB superfamily in ovarian cancer.
    Han J; Lyu L
    Discov Oncol; 2024 May; 15(1):198. PubMed ID: 38814534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and analysis of expression, prognosis and immune infiltration of WNT gene family in non-small cell lung cancer.
    Wang J; Yang Q; Tang M; Liu W
    Front Oncol; 2022; 12():911316. PubMed ID: 35957916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer.
    Liu D; Liu S; Fang Y; Liu L; Hu K
    Front Cell Dev Biol; 2021; 9():816230. PubMed ID: 35223869
    [No Abstract]   [Full Text] [Related]  

  • 9. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
    Zhou S; Wang P; Su X; Chen J; Chen H; Yang H; Fang A; Xie L; Yao Y; Yang J
    PLoS One; 2017; 12(10):e0187356. PubMed ID: 29088286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of four genes in exosomes as biomarkers for the identification of lung adenocarcinoma and lung squamous cell carcinoma.
    Cao B; Wang P; Gu L; Liu J
    Oncol Lett; 2021 Apr; 21(4):249. PubMed ID: 33664813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic analysis of IGF2BP family members in non-small-cell lung cancer.
    Gong L; Liu Q; Jia M; Sun X
    Hum Genomics; 2024 Jun; 18(1):63. PubMed ID: 38867248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shared network pattern of lung squamous carcinoma and adenocarcinoma illuminates therapeutic targets for non-small cell lung cancer.
    Li P; Kuang X; Zhang T; Ma L
    Front Surg; 2022; 9():958479. PubMed ID: 36263088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Wang J; Zhan X
    Front Immunol; 2021; 12():752643. PubMed ID: 34887858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of GLUT1 on the Survival Rate and Immune Cell Infiltration of Lung Adenocarcinoma and Squamous Cell Carcinoma: A Meta and Bioinformatics Analysis.
    Zhang G; Dong R; Kong D; Liu B; Zha Y; Luo M
    Anticancer Agents Med Chem; 2022; 22(2):223-238. PubMed ID: 34238200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of NR3C2 as a functional diagnostic and prognostic biomarker and potential therapeutic target in non-small cell lung cancer.
    Sun YY; Gao HC; Guo P; Sun N; Peng C; Cheng ZH; Gu J; Liu JY; Han F
    Cancer Innov; 2024 Aug; 3(4):e122. PubMed ID: 38948253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive bioinformatics analysis on exportins in lung adenocarcinoma and lung squamous cell carcinoma.
    Pan M; Huang P; Li L; Lei P; Fang L; Zhao L; Li Y; Huang S; Luo W
    J Thorac Dis; 2023 Apr; 15(4):1872-1891. PubMed ID: 37197486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the key genes and characterizations of Tumor Immune Microenvironment in Lung Adenocarcinoma (LUAD) and Lung Squamous Cell Carcinoma (LUSC).
    Zhang L; Chen J; Cheng T; Yang H; Li H; Pan C
    J Cancer; 2020; 11(17):4965-4979. PubMed ID: 32742444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Zengin T; Önal-Süzek T
    J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33672117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skp2 expression has different clinicopathological and prognostic implications in lung adenocarcinoma and squamous cell carcinoma.
    Zhong K; Yang F; Han Q; Chen J; Wang J
    Oncol Lett; 2018 Sep; 16(3):2873-2880. PubMed ID: 30127874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative bioinformatics analysis the clinical value of KMT5A in different subtypes of lung cancer.
    Liu S; Tian W; Li B
    Comput Biol Chem; 2022 Feb; 96():107603. PubMed ID: 34894606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.